Position in AZN
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$130,943,232
New position
Shares Held
663,945
first reported quarter
Ownership
0.043%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 91%
Shared 0%
None 9%
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026JENNISON ASSOCIATES LLC holds $5,990,626,556 across 6 Drug Manufacturers - General names. AZN ranks #5 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,060,878 | $4,654,843,757 | |
| 2 | MRK |
Merck & Co., Inc.
|
6,249,337 | $751,732,746 | |
| 3 | ABBV |
AbbVie Inc.
|
1,062,732 | $231,133,582 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
1,264,546 | $176,239,776 | |
| 5 | AZN |
Astrazeneca PLC
This page
|
663,945 | $130,943,232 | |
| 6 | AMGN |
Amgen Inc
|
129,980 | $45,733,463 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $130,943,232 | 663,945 | Shares | Defined | 2026-05-06 | |
| No filing history on record for this holder in this stock. | ||||||